Working… Menu
Trial record 44 of 104 for:    colon cancer | ( Map: Nebraska, United States )

Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer (PRIMUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01309126
Recruitment Status : Terminated (Due to enrollment challenges resulting from changing treatment patterns in the use of cetuximab, the study has been terminated. No patients remain on study.)
First Posted : March 4, 2011
Last Update Posted : July 13, 2017
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2017
Actual Study Completion Date : February 2017